Management of radiation oncology patients with implanted cardiac pacemakers: Report of AAPM Task Group No. 34 | Zendy

Marbach J. R. | Zendy; Sontag M. R. | Zendy; Van Dyk J. | Zendy; Wolbarst A. B. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Management of radiation oncology patients with implanted cardiac pacemakers: Report of AAPM Task Group No. 34

Author(s) -

Marbach J. R.,

Sontag M. R.,

Van Dyk J.,

Wolbarst A. B.

Publication year - 1994

Publication title -

medical physics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.473

H-Index - 180

eISSN - 2473-4209

pISSN - 0094-2405

DOI - 10.1118/1.597259

Subject(s) - radiation oncology , gray (unit) , medicine , radiation therapy , medical physicist , cardiac pacemaker , medical physics , radiation dose , task group , nuclear medicine , radiology , engineering , engineering management

Contemporary cardiac pacemakers can fail from radiation damage at doses as low as 10 gray and can exhibit functional changes at doses as low as 2 gray. A review and discussion of this potential problem is presented and a protocol is offered that suggests that radiation therapy patients with implanted pacemakers be planned so as to limit accumulated dose to the pacemaker to 2 gray. Although certain levels and types of electromagnetic interference can cause pacemaker malfunction, there is evidence that this is not a serious problem around most contemporary radiation therapy equipment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research